Drug Device Combination Product Market, By Products Type (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and

Drug Device Combination Product Market, By Products Type (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other Applications), By End-User (Hospitals, Ambulatory Surgical Centers, and Other End-users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments. Combination products include at least two products, one, of medical device and other of drugs that work in coordination to treat. Thus, there is an increase in demand for drug device combination products.

Market Dynamics:

Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the United States live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.

Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Key features of the study:

• This report provides in-depth analysis of the global drug device combination product market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market.

• Global Drug Device Combination Product Market, By Products:
• Drug Eluting Stents
• Transdermal Patches
• Infusion Pumps
• Drug Eluting Balloon
• Inhalers
• Other Products
• Global Drug Device Combination Product Market, By Application:
• Cardiovascular
• Diabetes
• Cancer Treatment
• Respiratory Diseases
• Other Applications
• Global Drug Device Combination Product Market, By End-Users:
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• Global Drug Device Combination Product Market, By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Company Profiles:
• AbbVie Inc. (Allergan)
• Terumo Corporation
• GlaxoSmithKline PLC
• Novartis AG
• Medtronic PLC
• Abbott Laboratories
• Boston Scientific Corp.
• W L Gore and Associates Inc.
• Stryker Corporation
• Becton, Dickinson and Company